Afuco™ Anti-Human PROKR1 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-PROKR1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that bind to cell surface-expressed prokineticin receptors (PROKRs), and the antibodies are useful for the treatment of various diseases and disorders mediated by prokineticin signaling, such as pain conditions and pathological angiogenesis condions.
Supplier Creative Biolabs
Product # AFC-710CL
Pricing Inquiry
Host Human
Target PROKR1
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at -20°C. Open under aseptic conditions.
Feedback